Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: A clinical study compared efficacy and safety of depot medroxyprogesterone acetate (DMPA) with leuprolide for endometriosis-associated pain. METHODS: This multicentre, 18 month, evaluator-blinded, comparator-controlled trial randomized 300 women with laparoscopically diagnosed endometriosis to 6 month treatment with subcutaneous injection of 104 mg/0.65 ml DMPA (DMPA-SC 104) every 3 months or leuprolide (3.75 mg monthly or 11.25 mg every 3 months), with 12 months post-treatment follow-up. Endpoints included patient response to treatment in five signs/symptoms (dysmenorrhoea, dyspareunia, pelvic pain, pelvic tenderness, induration) and changes in bone mineral density (BMD) and productivity at 6 and 18 months. RESULTS: DMPA-SC 104 and leuprolide produced equivalent (P < 0.02) reductions in at least four pain categories and significant (P < 0.001) improvements in composite score at months 6 and 18. At month 6, reductions in total hip and lumbar spine BMD were significantly less (P < 0.001) with DMPA-SC 104 versus leuprolide. BMD returned to pre-treatment levels 12 months post-treatment in the DMPA-SC 104 but not the leuprolide group. Total productivity also significantly (P < or = 0.05) improved in both groups at 6 and 18 months. CONCLUSIONS: DMPA-SC 104 reduces endometriosis-associated pain as effectively as leuprolide and improves productivity with significantly less BMD decline.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MPA appeared to be more effective than placebo [214] and as effective as danazol [215] and GnRH-agonists [216, 217] in reducing endometriosis-related pain.”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [216]
In the citing paper
“Depot medroxyprogesterone acetate (MPA; 104 mg, subcutaneous injection, every 3 months) has demonstrated an efficacy equivalent to LA, but long-term use of depot MPA preparations is shown to impact adversely on bone mineral density (BMD), while the delay in resumption of ovulation that may follow discontinuation of this therapy is a contraindication to use in women wishing to conceive in the near”
From Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial (2010) · cites this paper as Crosignani et al., 2006
In the citing paper
“Irregular uterine bleeding is a known adverse effect of treatment with progestins, including depot preparations of MPA, which have been compared in trials against LA (Vercellini et al., 2003;Crosignani et al., 2006;Schlaff et al., 2006).”
From Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial (2010) · cites this paper as Crosignani et al., 2006
In the citing paper
“In both studies DMPA-SC was statistically equivalent to GnRHa in reducing pain symptoms after 12 months' follow-up.”
From Oral and depot progestin therapy for endometriosis: towards a personalized medicine (2017) · cites this paper as [50]
In the citing paper
“Patients in the DMPA-SC group showed significantly less BMD loss than did leuprolide patients at month 6.”
From Oral and depot progestin therapy for endometriosis: towards a personalized medicine (2017) · cites this paper as [50]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Eskenazi, B., & Warner, M. L. (1997) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70302-8 · Cited by 1,617
ESHRE guideline for the diagnosis and treatment of endometriosis
Kennedy, S., Bergqvist, A., Chapron, C., D’Hooghe, T., Dunselman, G., Greb, R., Hummelshoj, L., Prentice, A., & Saridogan, E. (2005) · Human Reproduction · doi:10.1093/humrep/dei135 · Cited by 1,584
Self-citationSutton, C. J. G., Ewen, S. P., Whitelaw, N., & Haines, P. (1994) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56990-8 · Cited by 525
KUPPERMAN, H. S., BLATT, M. H. G., WIESBADER, H., & FILLER, W. (1953) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-13-6-688 · Cited by 478
Vercellini, P., Frontino, G., De Giorgi, O., Pietropaolo, G., Pasin, R., & Crosignani, P. G. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00794-5 · Cited by 289
Self-citationDlugi, A. M., Miller, J. D., & Knittle, J. (1990) · Fertility and Sterility · doi:10.1016/s0015-0282(16)53755-8 · Cited by 279
Epidemiology of endometriosis-associated infertility.
Wheeler, J. M. (1989) · PubMed · Cited by 270
Treatment of severe postmenopausal endometriosis with an aromatase inhibitor
Takayama, K., Zeitoun, K., Gunby, R. T., Sasano, H., Carr, B. R., & Bulun, S. E. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00022-3 · Cited by 270
Cited by
Clinical Management of Endometriosis
Falcone, T., & Flyckt, R. (2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002469 · Cited by 569
Consensus on current management of endometriosis
Johnson, N. P., Hummelshoj, L., for the World Endometriosis Society Montpellier Consortium, Abrao, M. S., Adamson, G. D., Allaire, C., Amelung, V., Andersson, E., Becker, C., Birna Árdal, K. B., et al. (2013) · Human Reproduction · doi:10.1093/humrep/det050 · Cited by 558
Progesterone and Estrogen Signaling in the Endometrium: What Goes Wrong in Endometriosis?
Marquardt, R. M., Kim, T. H., Shin, J.-H., & Jeong, J.-W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153822 · Cited by 491
Strowitzki, T., Marr, J., Gerlinger, C., Faustmann, T., & Seitz, C. (2010) · Human Reproduction · doi:10.1093/humrep/dep469 · Cited by 381
Systematic review of endometriosis pain assessment: how to choose a scale?
Bourdel, N., Alves, J., Pickering, G., Ramilo, I., Roman, H., & Canis, M. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmu046 · Cited by 372
Hormonal treatments for endometriosis: The endocrine background
Vannuccini, S., Clemenza, S., Rossi, M., & Petraglia, F. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09666-w · Cited by 336
Progesterone resistance in endometriosis: origins, consequences and interventions
Patel, B. G., Rudnicki, M., Yu, J., Shu, Y., & Taylor, R. N. (2017) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13156 · Cited by 336
Reevaluating response and failure of medical treatment of endometriosis: a systematic review
Becker, C. M., Gattrell, W. T., Gude, K., & Singh, S. S. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.05.004 · Cited by 302
Estrogen-progestins and progestins for the management of endometriosis
Vercellini, P., Buggio, L., Berlanda, N., Barbara, G., Somigliana, E., & Bosari, S. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.10.022 · Cited by 243
Advances in the management of endometriosis: an update for clinicians
Crosignani, P., Olive, D., Bergqvist, A., & Luciano, A. (2006) · Human Reproduction Update · doi:10.1093/humupd/dmi049 · Cited by 237
Self-citationEndometriosis: The Role of Neuroangiogenesis
Asante, A., & Taylor, R. N. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012110-142158 · Cited by 223
Leuprolide acetate: a drug of diverse clinical applications
Wilson, A. C., Vadakkadath Meethal, S., Bowen, R. L., & Atwood, C. S. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.11.1851 · Cited by 207
Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods
Bahamondes, L., Valeria Bahamondes, M., & Shulman, L. P. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv023 · Cited by 193
Medical treatment of endometriosis-related pain
Vercellini, P., Buggio, L., Frattaruolo, M. P., Borghi, A., Dridi, D., & Somigliana, E. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2018.01.015 · Cited by 188
Endometriosis: Current Therapies and New Pharmacological Developments
Vercellini, P., Somigliana, E., Viganò, P., Abbiati, A., Barbara, G., & Crosignani, P. G. (2009) · Drugs · doi:10.2165/00003495-200969060-00002 · Cited by 182
Self-citation“Waiting for Godot”: a commonsense approach to the medical treatment of endometriosis
Vercellini, P., Crosignani, P., Somigliana, E., Vigano, P., Frattaruolo, M. P., & Fedele, L. (2011) · Human Reproduction · doi:10.1093/humrep/deq302 · Cited by 180
Self-citationDienogest in the treatment of endometriosis: systematic review
Andres, M. D. P., Lopes, L. A., Baracat, E. C., & Podgaec, S. (2015) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3681-6 · Cited by 167
Pharmacologic therapies in endometriosis: a systematic review
Soares, S. R., Martínez‐Varea, A., Hidalgo‐Mora, J. J., & Pellicer, A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.07.1120 · Cited by 165
Aspectos atuais do diagnóstico e tratamento da endometriose
Nácul, A. P., & Spritzer, P. M. (2010) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1590/s0100-72032010000600008 · Cited by 155
Current and Emerging Therapeutics for the Management of Endometriosis
Ferrero, S., Barra, F., & Maggiore, U. L. R. (2018) · Drugs · doi:10.1007/s40265-018-0928-0 · Cited by 155
Bone density recovery after depot medroxyprogesterone acetate injectable contraception use
Kaunitz, A. M., Arias, R., & McClung, M. R. (2008) · Contraception · doi:10.1016/j.contraception.2007.10.005 · Cited by 155
Current and emerging treatment options for endometriosis
Ferrero, S., Evangelisti, G., & Barra, F. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1494154 · Cited by 152
Endometriosis: current and future medical therapies
Vercellini, P., Somigliana, E., Viganò, P., Abbiati, A., Daguati, R., & Crosignani, P. G. (2007) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2007.10.001 · Cited by 150
Self-citationTreatment of pain associated with deep endometriosis: alternatives and evidence
Ferrero, S., Alessandri, F., Racca, A., & Maggiore, U. L. R. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.08.031 · Cited by 144
Gerlinger, C., Schumacher, U., Faustmann, T., Colligs, A., Schmitz, H., & Seitz, C. (2010) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-8-138 · Cited by 134
Health-related quality of life in women with endometriosis: a systematic review
Jia, S.-Z., Leng, J.-H., Shi, J.-H., Sun, P.-R., & Lang, J.-H. (2012) · Journal of Ovarian Research · doi:10.1186/1757-2215-5-29 · Cited by 132
Walch, K., Unfried, G., Huber, J., Kurz, C., van Trotsenburg, M., Pernicka, E., & Wenzl, R. (2009) · Contraception · doi:10.1016/j.contraception.2008.07.017 · Cited by 128
Diamond, M. P., Carr, B. R., Dmowski, W. P., Koltun, W. D., O'Brien, C. F., Jiang, P. X., Burke, J., Jimenez, R., Garner, E. I. O., & Chwalisż, K. (2013) · Reproductive Sciences · doi:10.1177/1933719113497292 · Cited by 127
Carr, B., Dmowski, W. P., O’Brien, C., Jiang, P., Burke, J., Jimenez, R., Garner, E., & Chwalisz, K. (2014) · Reproductive Sciences · doi:10.1177/1933719114549848 · Cited by 114
Diagnosis and treatment of bladder endometriosis: state of the art
Maccagnano, C., Pellucchi, F., Rocchini, L., Ghezzi, M., Scattoni, V., Montorsi, F., Rigatti, P., & Colombo, R. (2012) · Urologia Internationalis · doi:10.1159/000339519 · Cited by 112
Barra, F., Scala, C., & Ferrero, S. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1461840 · Cited by 100
Maccagnano, C., Pellucchi, F., Rocchini, L., Ghezzi, M., Scattoni, V., Montorsi, F., Rigatti, P., & Colombo, R. (2013) · Urologia Internationalis · doi:10.1159/000345140 · Cited by 100
Deep dyspareunia and sex life after laparoscopic excision of endometriosis
Ferrero, S., Abbamonte, L. H., Giordano, M., Ragni, N., & Remorgida, V. (2007) · Human Reproduction · doi:10.1093/humrep/del465 · Cited by 98
Hormonal therapy for endometriosis: from molecular research to bedside
Tosti, C., Biscione, A., Morgante, G., Bifulco, G., Luisi, S., & Petraglia, F. (2017) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.05.032 · Cited by 96
WONG, A. Y. K., TANG, L. C. H., & CHIN, R. K. H. (2010) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2010.01152.x · Cited by 82
Safety of medical treatments for endometriosis
Berlanda, N., Somigliana, E., Viganò, P., & Vercellini, P. (2016) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2016.1121991 · Cited by 78
Evaluation and treatment of endometriosis.
Schrager, S., Falleroni, J., & Edgoose, J. Y. C. (2013) · PubMed · Cited by 75
Sansone, A., Rosa, N. D., Giampaolino, P., Guida, M., Laganà, A. S., & Carlo, C. D. (2018) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-4851-0 · Cited by 74
Pharmacological Treatment of Endometriosis: Experience with Aromatase Inhibitors
Ferrero, S., Venturini, P. L., Ragni, N., Camerini, G. B., & Remorgida, V. (2009) · Drugs · doi:10.2165/00003495-200969080-00001 · Cited by 70
A comprehensive review of hormonal and biological therapies for endometriosis: latest developments
Barra, F., Grandi, G., Tantari, M., Scala, C., Facchinetti, F., & Ferrero, S. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1581761 · Cited by 69
Katayama, H., Katayama, T., Uematsu, K., Hiratsuka, M., Kiyomura, M., Shimizu, Y., Sugita, A., & Ito, M. (2010) · Human Reproduction · doi:10.1093/humrep/deq241 · Cited by 68
Elagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled Study
Carr, B., Giudice, L., Dmowski, W. P., O'Brien, C., Jiang, P., Burke, J., Jimenez, R., Hass, S., Fuldeore, M., & Chwalisz, K. (2013) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.5301/je.5000157 · Cited by 64
Endometriosis: Diagnosis and Management
Leyland, N. A., Casper, R. F., Laberge, P. Y., Singh, S. S., Allen, L. M., Arendas, K., Leyland, N. A., Allaire, C., Awadalla, A., Best, C., et al. (2010) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.1177/228402651000200303 · Cited by 61
Chwalisz, K., Surrey, E., & Stanczyk, F. Z. (2012) · Reproductive Sciences · doi:10.1177/1933719112438061 · Cited by 58
Oral and depot progestin therapy for endometriosis: towards a personalized medicine
Buggio, L., Somigliana, E., Barbara, G., Frattaruolo, M. P., & Vercellini, P. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1381086 · Cited by 58
Current pharmacotherapy for endometriosis
Ferrero, S., Remorgida, V., & Venturini, P. L. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656561003685880 · Cited by 58
Grandi, G., Mueller, M., Bersinger, N., Papadia, A., Nirgianakis, K., Cagnacci, A., & McKinnon, B. (2016) · American Journal of Reproductive Immunology · doi:10.1111/aji.12552 · Cited by 55
Jones, G. L., Budds, K., Taylor-Phillips, F., Musson, D., Raymer, J., Churchman, D., Kennedy, S., & Jenkinson, C. (2023) · Human Reproduction Update · doi:10.1093/humupd/dmad029 · Cited by 55
Guilbert, É., Brown, J. P., Kaunitz, A. M., Wagner, M.-S., Bérubé, J., Charbonneau, L., Francoeur, D., Gilbert, A., Gilbert, F., Roy, G., et al. (2009) · Contraception · doi:10.1016/j.contraception.2008.10.016 · Cited by 55
Samy, A., Taher, A. M., Sileem, S., Abdelhakim, A. M., Fathi, M. M., Haggag, H. M., Ashour, K., Ahmed, S. A., Shareef, M. A., AlAmodi, A. A., et al. (2020) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2020.101798 · Cited by 54
Dogan‐Topal, B., & Özkan, S. A. (2010) · Talanta · doi:10.1016/j.talanta.2010.10.049 · Cited by 54
Dragoman, M. V., & Gaffield, M. E. (2016) · Contraception · doi:10.1016/j.contraception.2016.02.003 · Cited by 52
Cheewadhanaraks, S., Choksuchat, C., Dhanaworavibul, K., & Liabsuetrakul, T. (2012) · Gynecologic and Obstetric Investigation · doi:10.1159/000337713 · Cited by 51
The place of dydrogesterone in the treatment of endometriosis and adenomyosis
Schweppe, K.-W. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.11.011 · Cited by 51
Sanghera, S., Barton, P. M., Bhattacharya, S., Horne, A. W., & Roberts, T. E. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010580 · Cited by 49
Tolerability considerations for gonadotropin-releasing hormone analogues for endometriosis
Corte, L. D., Barra, F., Mercorio, A., Evangelisti, G., Rapisarda, A. M. C., Ferrero, S., Bifulco, G., & Giampaolino, P. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1789591 · Cited by 49
Progestin Therapy in Endometriosis
Gezer, A., & Oral, E. (2015) · Women's Health · doi:10.2217/whe.15.42 · Cited by 47
Novel drug delivery methods for improving efficacy of endometriosis treatments
Garzon, S., Laganà, A. S., Barra, F., Casarin, J., Cromi, A., Raffaelli, R., Uccella, S., Franchi, M. P., Ghezzi, F., & Ferrero, S. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1829589 · Cited by 46
Emerging therapy for endometriosis
Lindsay, S. F., Luciano, D. E., & Luciano, A. A. (2015) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2015.1051966 · Cited by 45
Self-citationThe role of progestins in treating the pain of endometriosis
Surrey, E. S. (2006) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2006.06.008 · Cited by 43
Use of Norethindrone Acetate Alone for Postoperative Suppression of Endometriosis Symptoms
Kaser, D. J., Missmer, S. A., Berry, K. F., & Laufer, M. R. (2012) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2011.09.013 · Cited by 42
Gonadotropin-releasing hormone analogues for endometriosis
Veth, V. B., van de Kar, M. M., Duffy, J. M., van Wely, M., Mijatovic, V., & Maas, J. W. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014788.pub2 · Cited by 39
Emerging drugs in endometriosis
Mihalyi, A., Simsa, P., Mutinda, K. C., Meuleman, C., Mwenda, J. M., & D’Hooghe, T. M. (2006) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.11.3.503 · Cited by 39
Targeting Mast Cells in Endometriosis with Janus Kinase 3 Inhibitor, JANEX‐1
D’Cruz, O. J., & Uckun, F. M. (2007) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2007.00502.x · Cited by 39
Taylor, H. S., Dun, E. C., & Chwalisz, K. (2019) · Pain Management · doi:10.2217/pmt-2019-0010 · Cited by 38
Female Sexual Function in Women with Suspected Deep Infiltrating Endometriosis
Lima, R. V., Pereira, A. M. G., Beraldo, F. B., Gazzo, C., Martins, J. A., & Lopes, R. G. C. (2018) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0038-1639593 · Cited by 38
Advances in targeting estrogen synthesis and receptors in patients with endometriosis
Clemenza, S., Vannuccini, S., Ruotolo, A., Capezzuoli, T., & Petraglia, F. (2022) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2152325 · Cited by 38
A peek into the drug development scenario of endometriosis – A systematic review
Goenka, L., George, M., & Sen, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.03.092 · Cited by 37
Management of endometriosis: Toward value-based, cost-effective, affordable care
Vercellini, P., Facchin, F., Buggio, L., Barbara, G., Berlanda, N., Frattaruolo, M. P., & Somigliana, E. (2018) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.07.011 · Cited by 36
Advances in pharmacotherapy for treating endometriosis
Tafi, E., Leone Roberti Maggiore, U., Alessandri, F., Bogliolo, S., Gardella, B., Vellone, V. G., Grillo, F., Mastracci, L., & Ferrero, S. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1085510 · Cited by 36
Effects of Dienogest on Surgically Induced Endometriosis in Rats after Repeated Oral Administration
Fischer, O. M., Kaufmann-Reiche, U., Moeller, C., & Fuhrmann, U. (2011) · Gynecologic and Obstetric Investigation · doi:10.1159/000331642 · Cited by 36
Contraception and endometriosis: challenges, efficacy, and therapeutic importance
Fraser, I. S., & Weisberg, E. (2015) · Open Access Journal of Contraception · doi:10.2147/oajc.s56400 · Cited by 36
Behnamfar, F., Ghahiri, A., & Tavakoli, M. (2014) · PubMed Central · Cited by 36
Gonadotropin-Releasing Hormone Antagonists—A New Hope in Endometriosis Treatment?
Rzewuska, A., Żybowska, M., Sajkiewicz, I., Spiechowicz, I., Żak, K., Abramiuk, M., Kułak, K., & Tarkowski, R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12031008 · Cited by 33
Reviewing the role of progesterone therapy in endometriosis
Karim, A., Shafiee, M. N., Aziz, N. H. A., Omar, M. H., Ghani, N. A. A., Lim, P. S., Zin, R. R. M., & Mokhtar, N. M. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1490404 · Cited by 33
Prospects for potential therapy targeting immune‑associated factors in endometriosis (Review)
Zhang, W., Li, K., Jian, A., Zhang, G., & Zhang, X. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13422 · Cited by 31
Bi, X.-L., & Xie, C. (2018) · Medicine · doi:10.1097/md.0000000000011266 · Cited by 30
Postoperative desogestrel for pelvic endometriosis-related pain: a randomized controlled trial
Tanmahasamut, P., Saejong, R., Rattanachaiyanont, M., Angsuwathana, S., Techatraisak, K., & Sa‐nga‐areekul, N. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1296124 · Cited by 27
Considerations for the use of progestin‐only contraceptives
Freeman, S. B., & SHULMAN, L. P. (2010) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2009.00473.x · Cited by 26
Wyrwich, K. W., O’Brien, C. F., Soliman, A. M., & Chwalisż, K. (2018) · Reproductive Sciences · doi:10.1177/1933719118789509 · Cited by 26
Chronic pelvic pain and endometriosis in adolescents
Solnik, M. J. (2006) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/01.gco.0000242953.94749.2b · Cited by 25
Bourdel, N., Roman, H., Mage, G., & Canis, M. J. (2011) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2011.07.051 · Cited by 25
The Pituitary Gland: Anatomy, Physiology, and its Function as the Master Gland
Barkhoudarian, G., & Kelly, D. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804340-0.00001-2 · Cited by 24
Moradan, S., Nikkhah, N., & Mirmohammadkhani, M. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0509-8 · Cited by 24
Innovations in conservative endometriosis treatment: an updated review.
Ruhland, B., Agic, A., Krampe, J., Diedrich, K., & Hornung, D. (2011) · PubMed · Cited by 23
Wang, S.-T., Johnson, S. J., Mitchell, D., Soliman, A. M., Vora, J. B., & Agarwal, S. K. (2019) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2018-0124 · Cited by 22
Bohn, J. A., Bullard, K. A., Rodriguez, M. I., & Ecker, A. M. (2021) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000004536 · Cited by 21
Subcutaneous versus Intramuscular Depot Methoxyprogesterone Acetate: A Comparative Review
Simon, M. A., & SHULMAN, L. P. (2006) · Women s Health · doi:10.2217/17455057.2.2.191 · Cited by 21
A review of phase II and III drugs for the treatment and management of endometriosis
Perrone, U., Evangelisti, G., Laganà, A. S., Bogliolo, S., Ceccaroni, M., Izzotti, A., Gustavino, C., Ferrero, S., & Barra, F. (2023) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2023.2296080 · Cited by 20
Smith, A. W., Asa, C. S., Edwards, B. S., Murdoch, W. J., & Skinner, D. C. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02271.x · Cited by 20
Bulun, S. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00025-1 · Cited by 19
Rosenberger, D. C., Mennicken, E., Schmieg, I., Medkour, T., Péchard, M., Sachau, J., Fuchtmann, F., Birch, J. V., Schnabel, K., Vincent, K., et al. (2024) · Pain · doi:10.1097/j.pain.0000000000003290 · Cited by 16
Medical management of endometriosis
Newmark, A., Luciano, D. E., Ulrich, A., & Luciano, A. A. (2021) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.21.04776-x · Cited by 16
Self-citationCooper, K. G., Bhattacharya, S., DANIELS, J. P., Cheed, V., Gennard, L., Leighton, L., Pirie, D., Melyda, M., Monahan, M., Weckesser, A., et al. (2024) · Health Technology Assessment · doi:10.3310/sqwy6998 · Cited by 15
National consensus on management patients with endometriosis
Запорожан, В. М., Татарчук, Т. Ф., & Володимирович, К. В. (2015) · Reproductive Endocrinology · doi:10.18370/2309-4117.2015.24.7-12 · Cited by 14
Taylor, R. N., & Lebovic, D. I. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00024-3 · Cited by 14
Progestagens for pain symptoms associated with endometriosis
Chen, I., Kives, S. L., Zakhari, A., Nguyen, D. B., Goldberg, H. R., Choudhry, A. J., Le, A.-L., Kowalczewski, E., & Schroll, J. B. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002122.pub3 · Cited by 13
Injectable contraception: issues and opportunities
Kaunitz, A. M., Peipert, J. F., & Grimes, D. A. (2014) · Contraception · doi:10.1016/j.contraception.2014.03.014 · Cited by 13
Allen, R. H., Kaunitz, A. M., & Hickey, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00018-6 · Cited by 11
Safety of current strategies to manage moderate to severe pain in patients with endometriosis
Ferrero, S., Barra, F., Vatteroni, G., Rosato, F. P., Evangelisti, G., Paudice, M., & Vellone, V. G. (2025) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2025.2547017 · Cited by 10
Metadata
- Authors
- Crosignani, P. G., Luciano, A., Ray, A., & Bergqvist, A.
- Affiliations
- University of Milan (IT)
- University of Connecticut (US)
- Pfizer (United States) (US)
- Danderyds sjukhus (SE)
- Corresponding author
- Crosignani, P.G.
- ORCID
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-21
- Volume
- 21
- Issue
- 1
- Pages
- 248-256
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2169590550
- Cited by
- 179
- References
- 42
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 5 · 2023: 7 · 2022: 4 · 2021: 6 · 2020: 8 · 2019: 9 · 2018: 14 · 2017: 10 · 2016: 6 · 2015: 11 · 2014: 7 · 2013: 10 · 2012: 10
- FWCI
- 5.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Keywords
- endometriosis, endometriosis-associated pain, depot medroxyprogesterone acetate, leuprolide, subcutaneous injection, dysmenorrhea, dyspareunia, pelvic pain, bone mineral density, bone loss, labor productivity, GnRH agonist, GnRH antagonist
- MeSH terms
- Administration, Cutaneous, Adult, Contraceptive Agents, Female, Endometriosis, Female, Fertility Agents, Female, Hip, Humans, Lumbar Vertebrae, Quality of Life, Radiography, Uterine Diseases, Bone Density, Leuprolide, Treatment Outcome, Medroxyprogesterone Acetate, Pelvic Pain, Antineoplastic Agents, Hormonal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.